Reaction

Pinealoblastoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 93 reports · 4 co-occurring drugs

As of the last recalculation, Pinealoblastoma appears in 93 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 8,777.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Zidovudine798,777.78,830.2
Lamivudine Oral743,200.53,209.9
Lamivudine752,802.72,809.6
Nevirapine331,268.41,273.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.